ARCHIVE

• PAL Amendments as Related to GMP Explained by Korosho Official
  May 12, 2003

• Legal Basis for Regenerative Medicine Regulations Proposed by JHSF
  May 12, 2003

• Allergan Launches Kyorin's Gatifloxacin Ophthalmic Solution in US
  May 12, 2003

• PRESS SEMINAR
  May 12, 2003

• Fujisawa: Sales Increase for 4 Consecutive Years
  May 12, 2003

• RESEARCH & DEVELOPMENT NEWS IN BRIEF
  May 12, 2003

• ON THE MOVE
  April 28, 2003

• DPC System Introduced at 15 Hospitals on April 1: PJ Survey
  April 28, 2003

• Drug Makers' Cooperation Sought in Providing Drugs for Physician-led Clinical Trials: Ihoken Meeting
  April 28, 2003

• Chuikyo Subcommittee Selects Top Priority Issues
  April 28, 2003

• IMSJ Discontinues Providing Info on Sales by Individual Medical Institutions
  April 28, 2003

• The 26th General Assembly of the Japan Medical Congress (2)
  April 28, 2003

• Novartis' Symmetrel to Be Focused on Original Indications
  April 28, 2003

• Clinical Proteome Center Opens in Tokyo Medical University
  April 28, 2003

• Japan SMO Association to Conduct SMO Status Survey as 1st Step
  April 28, 2003

• University of Tokyo to Start Investing in Venture Companies
  April 28, 2003

• BUSINESS NEWS IN BRIEF
  April 28, 2003

• RESEARCH & DEVELOPMENT NEWS IN BRIEF
  April 28, 2003

• ON THE MOVE
  April 28, 2003

• DIAGNOSTIC NEWS IN BRIEF
  April 28, 2003

ページ

• « 先頭
• ‹ Prev
• …
• 601
• 602
• 603
• 604
• 605
• 606
• 607
• 608
• 609
• …
• Next ›
• 最終 »